Moreau T, Gutman N, el Moujahed A, Esnard F, Gauthier F
Eur J Biochem. 1986 Sep 1;159(2):341-6. doi: 10.1111/j.1432-1033.1986.tb09873.x.
The potential kininogenic function of rat T kininogen has been studied in parallel with the cysteine-proteinase-inhibitory function also carried by this molecule. Proteolytic cleavage of the molecule was observed upon incubation with catalytic amounts of trypsin. These conditions do not permit any significant release of immunoreactive kinin and do not modify the total papain-inhibiting capacity of T kininogen. As trypsin concentration increases in the reaction mixture, immunoreactive kinin is liberated and the total papain-inhibiting capacity decreases accordingly, as indicated by titration studies. This decrease, however, does not exceed 50% of the initial value even at a trypsin concentration as high as 75 microM, indicating that only one of the two inhibitory sites has been inactivated. The remaining inhibitory fragment corresponds to a peptide of apparent Mr 24 000, which binds papain at least as well as native T kininogen. T kininogen, therefore, appears as a potent proteinase inhibitor and/or a proteinase inhibitor precursor, whereas its kininogenic function remains questionable since no specific kininogenase able to release T kinin or another kinin under physiologically compatible conditions has been found so far.
已对大鼠T激肽原的潜在激肽原生成功能与其同样具备的半胱氨酸蛋白酶抑制功能进行了平行研究。在与催化量的胰蛋白酶孵育时,观察到该分子发生了蛋白水解切割。这些条件不会导致任何显著量的免疫反应性激肽释放,也不会改变T激肽原的总木瓜蛋白酶抑制能力。如滴定研究所示,随着反应混合物中胰蛋白酶浓度的增加,免疫反应性激肽被释放出来,总木瓜蛋白酶抑制能力相应降低。然而,即使在胰蛋白酶浓度高达75微摩尔时,这种降低也不会超过初始值的50%,这表明两个抑制位点中只有一个被灭活。剩余的抑制片段对应于一个表观分子量为24000的肽段,它结合木瓜蛋白酶的能力至少与天然T激肽原一样强。因此,T激肽原表现为一种有效的蛋白酶抑制剂和/或蛋白酶抑制剂前体,而其激肽原生成功能仍存在疑问,因为到目前为止尚未发现能够在生理相容条件下释放T激肽或其他激肽的特异性激肽原酶。